搜尋





搜尋





市場行情
/
股票
/
tcrx
/

TScan Therapeutics Inc

TCRX

添加自選

0.743USD

-0.013-1.68%

收盤 07-31 16:00（美東）報價延遲15分鐘

42.28M總市值

虧損本益比TTM

TScan Therapeutics Inc

0.743

-0.013-1.68%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

TCRX 利潤表

您可以在這裡找到TScan Therapeutics Inc的年度或季度收入報告，以深入了解TScan Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

營業總收入

-54.77%982.00K

286.02%2.57M

139.37%2.51M

473.88%3.08M

283.57%2.17M

-90.78%665.00K

-73.01%1.05M

-82.97%536.00K

-91.68%566.00K

132.99%7.21M

15.58%3.89M

-22.39%3.15M

125.19%6.80M

8.44%3.10M

39.43%3.36M

42.42%4.06M

49.04%3.02M

258.99%2.85M

731.72%2.41M

--2.85M

--2.03M

--795.00K

--290.00K

--0.00

營業收入

-54.77%982.00K

286.02%2.57M

139.37%2.51M

473.88%3.08M

283.57%2.17M

-90.78%665.00K

-73.01%1.05M

-82.97%536.00K

-91.68%566.00K

132.99%7.21M

15.58%3.89M

-22.39%3.15M

125.19%6.80M

8.44%3.10M

39.43%3.36M

42.42%4.06M

49.04%3.02M

258.99%2.85M

731.72%2.41M

--2.85M

--2.03M

--795.00K

--290.00K

--0.00

營業費用

-21.60%30.12M

-34.65%24.43M

17.50%39.56M

20.43%41.73M

20.29%38.42M

30.84%37.38M

17.59%33.67M

24.83%34.65M

8.10%31.94M

31.38%28.57M

43.60%28.64M

43.81%27.76M

54.01%29.55M

27.49%21.74M

9.24%19.94M

42.69%19.30M

92.90%19.18M

98.21%17.06M

144.66%18.25M

140.87%13.53M

76.45%9.95M

--8.61M

--7.46M

--5.62M

--5.64M

研發費用

-27.29%21.30M

-39.21%17.84M

18.41%31.10M

19.48%32.11M

17.82%29.29M

31.01%29.35M

15.48%26.26M

26.62%26.88M

14.13%24.86M

43.59%22.41M

51.29%22.74M

46.45%21.23M

48.26%21.78M

23.76%15.60M

5.81%15.03M

34.19%14.49M

100.16%14.69M

111.40%12.61M

144.38%14.21M

139.92%10.80M

70.75%7.34M

--5.96M

--5.81M

--4.50M

--4.30M

折舊攤銷及損耗

2.21%693.00K

1.69%723.00K

-25.32%767.00K

-37.46%698.00K

-45.93%678.00K

-44.45%711.00K

-20.14%1.03M

-13.89%1.12M

-16.34%1.25M

-13.75%1.28M

2.80%1.29M

7.37%1.30M

25.44%1.50M

29.95%1.48M

18.47%1.25M

82.60%1.21M

154.80%1.20M

188.38%1.14M

205.20%1.06M

148.50%661.00K

111.26%469.00K

--396.00K

--346.00K

--266.00K

--222.00K

營業利潤

19.62%-29.14M

40.46%-21.86M

-13.58%-37.05M

-13.31%-38.65M

-15.55%-36.25M

-71.90%-36.71M

-31.82%-32.62M

-38.62%-34.11M

-37.95%-31.37M

-14.52%-21.36M

-49.28%-24.75M

-61.42%-24.61M

-40.71%-22.74M

-31.31%-18.65M

-4.65%-16.58M

-42.77%-15.25M

-104.13%-16.16M

-81.84%-14.20M

-120.92%-15.84M

-90.15%-10.68M

-40.49%-7.92M

---7.81M

---7.17M

---5.62M

---5.64M

淨非營業利息收入（費用）

利息收入

-58.53%1.16M

-43.00%1.58M

-44.73%2.04M

-29.81%2.39M

27.95%2.80M

6.97%2.78M

35.13%3.69M

121.97%3.41M

92.78%2.19M

188.12%2.60M

411.80%2.73M

929.53%1.53M

16128.57%1.14M

44950.00%901.00K

17700.00%534.00K

2880.00%149.00K

16.67%7.00K

-33.33%2.00K

200.00%3.00K

66.67%5.00K

-93.94%6.00K

--3.00K

--1.00K

--3.00K

--99.00K

利息費用

1.47%689.00K

-10.46%702.00K

-27.04%699.00K

-27.63%689.00K

-29.20%679.00K

-7.98%784.00K

-2.44%958.00K

-1.75%952.00K

0.31%959.00K

-12.62%852.00K

388.56%982.00K

--969.00K

--956.00K

--975.00K

--201.00K

----

特殊收入（費用）

----

-83.49%-2.00M

----

---1.09M

----

稅前利潤

16.00%-28.67M

35.83%-22.98M

-19.48%-35.71M

-16.71%-36.95M

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

除稅後利潤

16.00%-28.67M

35.83%-22.98M

-19.48%-35.71M

-16.71%-36.95M

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

持續經營利潤

16.00%-28.67M

35.83%-22.98M

-19.48%-35.71M

-16.71%-36.95M

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

歸属于母公司的淨利潤

16.00%-28.67M

35.83%-22.98M

-19.48%-35.71M

-16.71%-36.95M

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

歸屬普通股東的淨利潤

16.00%-28.67M

35.83%-22.98M

-19.48%-35.71M

-16.71%-36.95M

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

基本每股收益

16.16%-0.22

40.29%-0.18

-9.23%-0.28

-2.04%-0.28

17.16%-0.26

-43.92%-0.30

-3.83%-0.25

45.19%-0.28

65.89%-0.32

73.52%-0.21

64.06%-0.24

18.82%-0.51

-38.21%-0.93

-29.17%-0.78

-0.49%-0.67

-38.64%-0.63

-100.90%-0.67

-81.89%-0.60

-120.91%-0.67

-90.17%-0.45

-42.89%-0.34

---0.33

---0.30

---0.24

---0.23

稀釋每股收益

16.16%-0.22

40.29%-0.18

-9.23%-0.28

-2.04%-0.28

17.16%-0.26

-43.92%-0.30

-3.83%-0.25

45.19%-0.28

65.89%-0.32

73.52%-0.21

64.06%-0.24

18.82%-0.51

-38.21%-0.93

-29.17%-0.78

-0.49%-0.67

-38.64%-0.63

-100.90%-0.67

-81.89%-0.60

-120.91%-0.67

-90.17%-0.45

-42.89%-0.34

---0.33

---0.30

---0.24

---0.23

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 TScan Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 TCRX 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

TScan Therapeutics Inc 財年末的營收是多少？



TScan Therapeutics Inc 2025 財年營收為 10.32M，高於上一財年的 2.82M。

TScan Therapeutics Inc 最近一個季度的營收是多少？



TScan Therapeutics Inc 最近一個季度的營收為 982.00K，同比增長 -54.77%。

TScan Therapeutics Inc 全年的淨利潤是多少？



TScan Therapeutics Inc 2025 財年淨利潤為 -129.77M。

TScan Therapeutics Inc 上一季度的淨利潤是多少？



TScan Therapeutics Inc 最近一個季度的淨利潤為 -28.67M。

TScan Therapeutics Inc 年度營業利潤是多少？



TScan Therapeutics Inc 2025 財年的營業利潤為 -133.81M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。